Meropenem Bradex 500 mg inj./inf. sol. (pwdr.) i.v. Բելգիա - անգլերեն - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

meropenem bradex 500 mg inj./inf. sol. (pwdr.) i.v.

bradex s.a. - meropenem trihydrate 570 mg - eq. meropenem anhydrous 500 mg - powder for solution for injection/infusion - 500 mg - meropenem trihydrate 570 mg - meropenem

Meropenem Fresenius Kabi 500 mg inj./inf. sol. (pwdr.) i.v. vial Բելգիա - անգլերեն - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

meropenem fresenius kabi 500 mg inj./inf. sol. (pwdr.) i.v. vial

fresenius kabi sa-nv - meropenem trihydrate 570 mg - eq. meropenem 500 mg - powder for solution for injection/infusion - 500 mg - meropenem trihydrate 570 mg - meropenem

Meropenem Ranbaxy 500 mg inj./inf. sol. (pwdr.) i.v. vial Բելգիա - անգլերեն - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

meropenem ranbaxy 500 mg inj./inf. sol. (pwdr.) i.v. vial

ranbaxy (uk) (5) ltd. - meropenem trihydrate 570 mg - eq. meropenem anhydrous 500 mg - powder for solution for injection/infusion - 500 mg - meropenem trihydrate 570 mg - meropenem

MEROPENEM JUNO meropenem (as trihydrate) 500 mg powder for injection vial Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

meropenem juno meropenem (as trihydrate) 500 mg powder for injection vial

juno pharmaceuticals pty ltd - meropenem trihydrate, quantity: 570 mg - injection, powder for - excipient ingredients: sodium carbonate - meropenem juno is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics:,,? community acquired lower respiratory tract infection ,,? hospital acquired lower respiratory tract infection,,? complicated urinary tract infection,,? febrile neutropaenia,,? intra-abdominal and gynaecological (poly microbial) infections,,? complicated skin and skin structure infections,,? meningitis,,? septicaemia

MEROPENEM JUNO meropenem (as trihydrate) 1 g powder for injection vial Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

meropenem juno meropenem (as trihydrate) 1 g powder for injection vial

juno pharmaceuticals pty ltd - meropenem trihydrate, quantity: 1140 mg - injection, powder for - excipient ingredients: sodium carbonate - meropenem juno is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics:,,? community acquired lower respiratory tract infection ,,? hospital acquired lower respiratory tract infection,,? complicated urinary tract infection,,? febrile neutropaenia,,? intra-abdominal and gynaecological (poly microbial) infections,,? complicated skin and skin structure infections,,? meningitis,,? septicaemia

Meropenem Mylan 500 mg inj./inf. sol. (pwdr.) i.v. vial Բելգիա - անգլերեն - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

meropenem mylan 500 mg inj./inf. sol. (pwdr.) i.v. vial

viatris gx bv-srl - meropenem trihydrate 570,78 mg - eq. meropenem 500 mg - powder for solution for injection/infusion - 500 mg - meropenem trihydrate 570.78 mg - meropenem

Meropenem Venus Pharma 500 mg inj./inf. sol. (pwdr.) i.v. vial Բելգիա - անգլերեն - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

meropenem venus pharma 500 mg inj./inf. sol. (pwdr.) i.v. vial

venus pharma gmbh - meropenem trihydrate 570,5 mg - eq. meropenem 500 mg - powder for solution for injection/infusion - 500 mg - meropenem trihydrate 570.5 mg - meropenem

Meropenem 1g, powder for solution for injection Մալթա - անգլերեն - Medicines Authority

meropenem 1g, powder for solution for injection

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - meropenem - powder for solution for infusion or injection - meropenem 1 g - antibacterials for systemic use

MEROPENEM MAXRX meropenem (as trihydrate) 500 mg powder for injection vial Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

meropenem maxrx meropenem (as trihydrate) 500 mg powder for injection vial

lupin australia pty limited - meropenem trihydrate, quantity: 570 mg (equivalent: meropenem, qty 500 mg) - injection, powder for - excipient ingredients: sodium carbonate - meropenem is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics: *community acquired lower respiratory tract infection *hospital acquired lower respiratory tract infection *complicated urinary tract infection *febrile neutropenia *intra-abdominal and gynaecological (poly microbial) infections *complicated skin and skin structure infections *meningitis *septicaemia

MEROPENEM MAXRX meropenem (as trihydrate) 1 g powder for injection vial Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

meropenem maxrx meropenem (as trihydrate) 1 g powder for injection vial

lupin australia pty limited - meropenem trihydrate, quantity: 1140 mg (equivalent: meropenem, qty 1000 mg) - injection, powder for - excipient ingredients: sodium carbonate - meropenem is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics: *community acquired lower respiratory tract infection *hospital acquired lower respiratory tract infection *complicated urinary tract infection *febrile neutropenia *intra-abdominal and gynaecological (poly microbial) infections *complicated skin and skin structure infections *meningitis *septicaemia